본문으로 건너뛰기
← 뒤로

When should the effectiveness of a botulinum toxin A for chronic migraine be assessed in the face of newest International Headache Society recommendations?

Cephalalgia : an international journal of headache 2025 Vol.45(7) p. 3331024251363268 🔓 OA Migraine and Headache Studies
OpenAlex 토픽 · Migraine and Headache Studies Ophthalmology and Eye Disorders Sympathectomy and Hyperhidrosis Treatments

Boczarska-Jedynak M, Blumenfeld AM

관련 도메인

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Magdalena Boczarska‐Jedynak, Andrew Blumenfeld (2025). When should the effectiveness of a botulinum toxin A for chronic migraine be assessed in the face of newest International Headache Society recommendations?. Cephalalgia : an international journal of headache, 45(7), 3331024251363268. https://doi.org/10.1177/03331024251363268
MLA Magdalena Boczarska‐Jedynak, et al.. "When should the effectiveness of a botulinum toxin A for chronic migraine be assessed in the face of newest International Headache Society recommendations?." Cephalalgia : an international journal of headache, vol. 45, no. 7, 2025, pp. 3331024251363268.
PMID 40734478

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
질환 migraine C0149931
Migraine Disorders
scispacy 1
질환 Headache C0018681
Headache
scispacy 1
기타 botulinum toxin A scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

같은 제1저자의 인용 많은 논문 (2)

관련 논문